Alice Bergamini

ORCID: 0000-0002-1915-8313
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ovarian cancer diagnosis and treatment
  • Endometrial and Cervical Cancer Treatments
  • Reproductive Biology and Fertility
  • Gestational Trophoblastic Disease Studies
  • PARP inhibition in cancer therapy
  • Ovarian function and disorders
  • Intraperitoneal and Appendiceal Malignancies
  • Prenatal Screening and Diagnostics
  • Endometriosis Research and Treatment
  • Testicular diseases and treatments
  • Uterine Myomas and Treatments
  • Sarcoma Diagnosis and Treatment
  • Ectopic Pregnancy Diagnosis and Management
  • Renal cell carcinoma treatment
  • Cancer Genomics and Diagnostics
  • CAR-T cell therapy research
  • Cervical Cancer and HPV Research
  • COVID-19 and healthcare impacts
  • Cancer Immunotherapy and Biomarkers
  • Gynecological conditions and treatments
  • Reproductive System and Pregnancy
  • Genital Health and Disease
  • BRCA gene mutations in cancer
  • CRISPR and Genetic Engineering
  • Reproductive tract infections research

Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
2016-2025

Vita-Salute San Raffaele University
2016-2025

Istituti di Ricovero e Cura a Carattere Scientifico
2016-2025

IRCCS Ospedale San Raffaele
2015-2025

Ospedale Maggiore
2025

San Raffaele University of Rome
2013-2024

University of Milan
2022-2024

Charing Cross Hospital
2023

Mylan (Switzerland)
2019

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
2016-2018

The objective of this work is to assess the 5-year outcomes patients undergoing conization for high-grade cervical lesions that simultaneously present as risk factors in persistence HPV infection and positivity surgical resection margins. This a retrospective study evaluating lesions. All included had both positive margins experienced at 6 months. Associations were evaluated with Cox proportional hazard regression summarized using ratio (HR). charts 2966 reviewed. Among whole population, 163...

10.3390/vaccines11030698 article EN cc-by Vaccines 2023-03-18
Giorgio Bogani Violante Di Donato Giovanni Scambia Fabio Landoni Fabio Ghezzi and 95 more Ludovico Muzii Pierluigi Benedetti Panici Francesco Raspagliesi Giorgio Bogani Violante Di Donato Giovanni Scambia Fabio Ghezzi Jvan Casarin Fabio Landoni Giampaolo Di Martino Tommaso Grassi Anna Myriam Perrone Pierandrea De Iaco Francesco Multinu Roberto Berretta Vito Andrea Capozzi Errico Zupi Gabriele Centini Antonio Pellegrino Silvia Corso Stefania Stevenazzi Anna Chiara Boschi Giuseppe Comerci Pantaleo Greco Gennaro Scutiero Francesco Sopracordevole Giorgio Giorda Mariasole Fichera Tommaso Simoncini Marta Caretto Enrico Sartori Federico Ferrari Antonio Cianci Giuseppe Sarpietro Maria Grazia Matarazzo Pierluigi Giampaolino Giuseppe Bifulco Michele Morelli Michele Di Dio Annamaria Ferrero Nicoletta Biglia Fabio Barra Simone Ferrero Stefano Cianci Vito Chiàntera Gabriella Sozzi Alfredo Ercoli Sergio Schettini Teresa Orlando Francesco Cannone Giuseppe Ettore Andrea Puppo Elena Olearo Umberto Leone Roberti Maggiore Valeria Artuso Innocenza Palaia Giorgia Perniola Rossana Tripodi Tullio Golia D’Augè Ilaria Cuccu Margherita Fischetti Giusi Santangelo Assunta Casorelli Andrea Giannini Ottavia D’Oria Giuseppe Vizzielli Stefano Restaino Alice Bergamini Luca Bocciolone Francesco Plotti Roberto Angioli Giulia Mantovani Marcello Ceccaroni C. Cassini Mattia Dominoni Laura Giambanco Silvia Amodeo Livio Leo Raphaël Thommaset Diego Raimondo Renato Seracchioli Mario Malzoni Francesca Falcone Franco Gorlero Martina Di Luca Enrico Busato Sami Kilzie A Dell’Acqua Giovanna Scarfone Paolo Vercellini Marco Petrillo Giampiero Capobianco Andrea Ciavattini Liliana Mereu Paolo Scollo

10.1016/j.ygyno.2022.07.022 article EN Gynecologic Oncology 2022-07-29

Background: Cervical dysplasia persistence/recurrence has a great impact on women's health and quality of life. In this study, we investigated whether prognostic nomogram may improve risk assessment after primary conization. Methods: This is retrospective multi-institutional study based charts consecutive patients undergoing conization between 1 January 2010 31 December 2014. A assessing the importance different variables was built. cohort treated 2015 30 June 2016 used to validate nomogram....

10.3390/vaccines10040579 article EN cc-by Vaccines 2022-04-09

Background To date, T cells redirected with CD19-specific chimeric antigen receptors (CAR) have gained impressive success in B-cell malignancies. However, treatment failures are common and the occurrence of severe toxicities, such as cytokine release syndrome (CRS), still limits full exploitation this approach. Therefore, development cell products improved therapeutic indexes is highly demanded. Methods In project, we investigated how CD4 CD8 populations cooperate during CD19 CAR-T responses...

10.1136/jitc-2022-005878 article EN cc-by Journal for ImmunoTherapy of Cancer 2023-01-01
Ignace Vergote José Alejandro Pérez Fidalgo Erika Hamilton Giorgio Valabrega Toon Van Gorp and 95 more Jalid Sehouli David Cibula Tally Levy Stephen Welch Debra L. Richardson Eva Guerra Giovanni Scambia Stéphanie Henry Pauline Wimberger David S. Miller Jaroslav Klát Jerónimo Martínez Francesco Raspagliesi Bhavana Pothuri Ignacio Romero Alice Bergamini Brian M. Slomovitz Fabienne Schochter Estrid Høgdall Lorena Fariñas-Madrid Bradley J. Monk Dayana Michel Michael Kauffman Sharon Shacham Mansoor Raza Mirza Vicky Makker Ignace Vergote Toon Van Gorp Isabelle Cadron Annelore Barbeaux Nathalie Cornez Stéphanie Henry Joseph Kerger Debbie Debaere Hannelore Denys Mansoor Raza Mirza Amit M. Oza Lucy Gilbert Stephen Welch Michael Kolinsky Qi Zhou Jing Wang Yingjie Yang Kaijia Tu Li Wang Danbo Wang Ge Lou Xiaojian Yan Jiaxin Yang David Cibula Jaroslav Klát Bohuslav Melichar Michal Zikán Klaudia Reginacova Vít Weinberger Jalid Sehouli Pauline Wimberger Dirk Bauerschlag Fabian Trillsch Oliver Tomé Fabienne Schochter Marco Johannes Battista Bahriye Aktas Kristina Luebbe Mustafa Deryal George Fountzilas Athina Christopoulou Christos Papadimitriou Flora Zagouri Limor Helpman Tamar Safra Tally Levy Ilan Bruchim Ora Rosengarten Aviad Zick Giorgio Valabrega Giovanni Scambia Giorgia Mangili Francesco Raspagliesi Carmela Pisano Donata Sartori Ugo De Giorgi José Alejandro Pérez Fidalgo César Gómez-Raposo Ignacio Romero María Iglesias Ana Santaballa Nerea Ancizar Purificación Estévez Constanza Maximiano A. Yubero Ana Oaknin Eva Guerra Lydia Gaba Jerónimo Martínez

PURPOSE Selinexor inhibits exportin-1 (XPO1) resulting in nuclear accumulation of tumor suppressor proteins including p53 and has clinical activity endometrial cancer (EC). The primary end point was to assess progression-free survival (PFS) with once-weekly oral selinexor patients advanced or recurrent EC. PATIENTS AND METHODS ENGOT-EN5/GOG-3055/SIENDO a randomized, prospective, multicenter, double-blind, placebo-controlled, phase III study at 107 sites 10 countries. Patients 18 years older...

10.1200/jco.22.02906 article EN cc-by-nc-nd Journal of Clinical Oncology 2023-09-05

Purpose Platinum-based chemotherapy (PBC) for patients with progressing ovarian cancer (OC) is more effective a longer time interval from previous platinum treatment (platinum-free [PFI]). In 1999, it was hypothesized that prolonging PFI single-agent non-PBC (NPBC) may offer strategy to improve overall outcome. MITO-8 aimed verify this hypothesis commonly used in clinical practice although has not been prospectively tested. Methods an open-label, prospective, randomized, superiority trial....

10.1200/jco.2017.73.4293 article EN Journal of Clinical Oncology 2017-08-21

Fertility issues have become critical in the management and counseling of BRCA mutation carriers. In this setting four points deserve consideration. (1) Women general lose their ability to conceive at a mean age 41 years, thus suggested policy prophylactic bilateral salpingo-oophorectomy 40 for carriers does not affect chances natural pregnancy. Conversely, if procedure is chosen 35 years old, oocyte cryopreservation prior surgery should be considered. (2) Some evidence suggests that ovarian...

10.1093/humrep/dex356 article EN Human Reproduction 2017-11-10

Background: Primary prevention through vaccination is a prophylactic approach aiming to reduce the risk of developing human papillomavirus (HPV)-related lesions. No mature and long-term data supported adoption in women undergoing conization. Methods: This retrospective multi-institutional study. Charts consecutive patients conization between 2010 2014 were collected. All included had at least 5 years follow-up. We compared outcomes plus alone. A propensity-score matching algorithm was...

10.3390/vaccines8040717 article EN cc-by Vaccines 2020-12-01

The assessment of deep myometrial invasion (MI) and lymph node involvement is utmost importance in the preoperative staging endometrial cancer (EC). Imaging parameters derived respectively from MRI PET have shown good predictive value. main aim present study to assess diagnostic performance hybrid 18F-FDG PET/MRI EC staging, with particular focus on MI lymphnodal detection.Prospective monocentric including 35 patients biopsy-proven undergoing (December 2018-March 2021) for purpose....

10.1097/rlu.0000000000004064 article EN Clinical Nuclear Medicine 2022-01-24
Coming Soon ...